Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum

The work was undertaken under the sponsorship and management of Cancer Research UK Centre for Drug Development and Cancer Research UK Centre Award (no. CTRQQR-2021100003). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

留言 (0)

沒有登入
gif